Pay in 4 interest-free payments of $35.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Preclinical data suggest potential in autoimmune disorder research
and are intended for educational and investigative use:
positioning PNC-27 as a valuable asset for researchers investigating cancer cell death pathways
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)
CJC-1295 no DAC significantly reduced visceral and subcutaneous fat mass
TB-500 (Thymosin Beta-4) 10mg Preclinical data suggest potential inOverview TB 500 is the synthetic, acetylated active fragment (1723) of Thymosin Beta 4, represented by the sequence Ac LKKTETQ. This research peptide is widely studied in laboratory and preclinical environments for its involvement in actin regulation, cellular migration, angiogenesis, tissue remodeling, and inflammatory pathway modulation. Due to its defined active region and smaller molecular size, TB 500 is frequently utilized in in vitro and animal
